Jack H. Lai

2.3k total citations
34 papers, 1.7k citations indexed

About

Jack H. Lai is a scholar working on Oncology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Jack H. Lai has authored 34 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 18 papers in Molecular Biology and 10 papers in Cellular and Molecular Neuroscience. Recurrent topics in Jack H. Lai's work include Peptidase Inhibition and Analysis (19 papers), Neuropeptides and Animal Physiology (10 papers) and Chemical Synthesis and Analysis (7 papers). Jack H. Lai is often cited by papers focused on Peptidase Inhibition and Analysis (19 papers), Neuropeptides and Animal Physiology (10 papers) and Chemical Synthesis and Analysis (7 papers). Jack H. Lai collaborates with scholars based in United States, Australia and Japan. Jack H. Lai's co-authors include Lewis C. Cantley, William W. Bachovchin, Michael B. Yaffe, Toshiyuki Obata, Stefano Volinia, Germán Leparc, Wengen Wu, David G. Sanford, Sarah E. Poplawski and James L. Sudmeier and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Nature Biotechnology.

In The Last Decade

Jack H. Lai

34 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jack H. Lai United States	19	1.1k	607	260	207	196	34	1.7k
Clifford Quan United States	24	1.2k 1.1×	405 0.7×	192 0.7×	294 1.4×	163 0.8×	38	2.0k
Jeffrey H. Till United States	11	1.3k 1.1×	431 0.7×	98 0.4×	166 0.8×	124 0.6×	12	1.9k
Jeremy Murray United States	22	1.4k 1.2×	311 0.5×	99 0.4×	204 1.0×	86 0.4×	36	1.8k
Darrin D. Stuart United States	25	1.7k 1.5×	819 1.3×	241 0.9×	169 0.8×	54 0.3×	50	2.3k
Takuya Furuta Japan	22	719 0.6×	272 0.4×	348 1.3×	268 1.3×	65 0.3×	101	1.7k
Dominico Vigil United States	19	1.7k 1.5×	396 0.7×	177 0.7×	137 0.7×	61 0.3×	26	2.0k
Nachiket Vartak Germany	13	1.4k 1.2×	469 0.8×	167 0.6×	150 0.7×	92 0.5×	17	1.9k
Qingkai Yang China	21	1.3k 1.1×	310 0.5×	227 0.9×	135 0.7×	73 0.4×	37	1.7k
Anuradha S. Raghavan United States	12	1.0k 0.9×	234 0.4×	95 0.4×	293 1.4×	91 0.5×	15	1.4k
Bi‐Ching Sang United States	18	1.2k 1.1×	711 1.2×	100 0.4×	337 1.6×	134 0.7×	30	2.2k

Countries citing papers authored by Jack H. Lai

Since Specialization

Citations

This map shows the geographic impact of Jack H. Lai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jack H. Lai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jack H. Lai more than expected).

Fields of papers citing papers by Jack H. Lai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jack H. Lai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jack H. Lai. The network helps show where Jack H. Lai may publish in the future.

Co-authorship network of co-authors of Jack H. Lai

This figure shows the co-authorship network connecting the top 25 collaborators of Jack H. Lai. A scholar is included among the top collaborators of Jack H. Lai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jack H. Lai. Jack H. Lai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Poplawski, Sarah E., Robin Hallett, Shuang Pan, et al.. (2023). Preclinical Development of PNT6555, a Boronic Acid–Based, Fibroblast Activation Protein-α (FAP)–Targeted Radiotheranostic for Imaging and Treatment of FAP-Positive Tumors. Journal of Nuclear Medicine. 65(1). 100–108. 20 indexed citations

McLaughlin, F. A., Sarah E. Poplawski, David G. Sanford, et al.. (2022). Abstract 1815: AVA6000, a novel Precision medicine, targeted to the tumor microenvironment via Fibroblast Activation Protein (FAP) mediated cleavage. Cancer Research. 82(12_Supplement). 1815–1815. 5 indexed citations

Panaro, Brandon L., Jacqueline L. Beaudry, Elodie M. Varin, et al.. (2018). Fibroblast activation protein is dispensable for control of glucose homeostasis and body weight in mice. Molecular Metabolism. 19. 65–74. 19 indexed citations

DiMare, Matthew T., et al.. (2016). Human FGF-21 Is a Substrate of Fibroblast Activation Protein. PLoS ONE. 11(3). e0151269–e0151269. 54 indexed citations

Okondo, Marian C., Darren C. Johnson, Ramya Sridharan, et al.. (2016). DPP8 and DPP9 inhibition induces pro-caspase-1-dependent monocyte and macrophage pyroptosis. Nature Chemical Biology. 13(1). 46–53. 226 indexed citations

Akopian, Tatos, Olga Kandror, Christopher Tsu, et al.. (2015). Cleavage Specificity of Mycobacterium tuberculosis ClpP1P2 Protease and Identification of Novel Peptide Substrates and Boronate Inhibitors with Anti-bacterial Activity. Journal of Biological Chemistry. 290(17). 11008–11020. 48 indexed citations

Bachovchin, Daniel A., Luke W. Koblan, Wengen Wu, et al.. (2014). A high-throughput, multiplexed assay for superfamily-wide profiling of enzyme activity. Nature Chemical Biology. 10(8). 656–663. 60 indexed citations

Donahue, Renee N., Brynn B. Duncan, Terry J. Fry, et al.. (2014). A pan inhibitor of DASH family enzymes induces immunogenic modulation and sensitizes murine and human carcinoma cells to antigen-specific cytotoxic T lymphocyte killing: implications for combination therapy with cancer vaccines. Vaccine. 32(26). 3223–3231. 11 indexed citations

Duncan, Brynn B., Steven L. Highfill, Haiying Qin, et al.. (2013). A Pan-Inhibitor of DASH Family Enzymes Induces Immune-mediated Regression of Murine Sarcoma and Is a Potent Adjuvant to Dendritic Cell Vaccination and Adoptive T-cell Therapy. Journal of Immunotherapy. 36(8). 400–411. 12 indexed citations

10.

Wu, Wengen, Yuxin Liu, Peng Zhao, et al.. (2012). 4-Substituted boro-proline dipeptides: Synthesis, characterization, and dipeptidyl peptidase IV, 8, and 9 activities. Bioorganic & Medicinal Chemistry Letters. 22(17). 5536–5540. 10 indexed citations

11.

Poplawski, Sarah E., et al.. (2011). Pro-Soft Val-boroPro: A Strategy for Enhancing in Vivo Performance of Boronic Acid Inhibitors of Serine Proteases. Journal of Medicinal Chemistry. 54(7). 2022–2028. 20 indexed citations

12.

Lai, Jack H., Wengen Wu, Yuhong Zhou, et al.. (2007). Synthesis and Characterization of Constrained Peptidomimetic Dipeptidyl Peptidase IV Inhibitors: Amino-Lactam boroAlanines. Journal of Medicinal Chemistry. 50(10). 2391–2398. 13 indexed citations

13.

Lai, Jack H., Yuhong Zhou, James L. Sudmeier, et al.. (2005). Microscopic Acid-Base Equilibra of Alanyl-boroAlanine. Kluwer Academic Publishers eBooks. 524. 333–338. 2 indexed citations

14.

Cheng, Jonathan D., Matthildi Valianou, Adrian A. Canutescu, et al.. (2005). Abrogation of fibroblast activation protein enzymatic activity attenuates tumor growth. Molecular Cancer Therapeutics. 4(3). 351–360. 112 indexed citations

15.

Bhat, Krishna L., et al.. (2005). Intramolecular dative bonds involving boron with oxygen and nitrogen in boronic acids and esters: a computational study. Journal of Molecular Structure THEOCHEM. 723(1-3). 147–157. 26 indexed citations

16.

Yaffe, Michael B., Germán Leparc, Jack H. Lai, et al.. (2001). A motif-based profile scanning approach for genome-wide prediction of signaling pathways. Nature Biotechnology. 19(4). 348–353. 455 indexed citations

17.

Nishikawa, Kiyotaka, Sansana Sawasdikosol, David A. Fruman, et al.. (2000). A Peptide Library Approach Identifies a Specific Inhibitor for the ZAP-70 Protein Tyrosine Kinase. Molecular Cell. 6(4). 969–974. 28 indexed citations

18.

Ziv, Yael, Doug W. Chan, Susan P. Lees‐Miller, et al.. (2000). Utilization of Oriented Peptide Libraries to Identify Substrate Motifs Selected by ATM. Journal of Biological Chemistry. 275(30). 22719–22727. 148 indexed citations

19.

Lai, Jack H., et al.. (1998). The design, synthesis and activity of pentapeptide pp60^c‐src inhibitors containing L‐phosphotyrosine mimics. Journal of Peptide Research. 51(4). 271–281. 14 indexed citations

20.

Lai, Jack H., Hà Phạm, & David Hangauer. (1996). Synthesis of a Vicinal Tricarbonyl Amide Derivative of l-Phenylalanine. The Journal of Organic Chemistry. 61(5). 1872–1874. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact